All Roll Calls
Yes: 115 • No: 7
South DakotaHB 1016101st South Dakota Legislature (2026)House
modify provisions related to the controlled substances schedule and to declare an emergency.
Sponsored By: Sponsor information unavailable
Signed by Governor
Controlled SubstancesEmergency ClauseExecutive/Judiciary RequestPublic Health and Safety
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
More drug restrictions for users and sellers
Effective immediately upon passage and approval, South Dakota adds N-Desethyl Isotonitazene, ethylphenidate, and 2-Methyl AP-237 to Schedule I. The listings cover their isomers, esters, ethers, and salts where chemically possible, unless specifically excepted. People making, selling, or possessing these drugs face existing Schedule I restrictions and penalties. The law also expands drug lookalike rules to cover specified halogen substitutions and related chemical changes called alkyl homologs. Other substances intended for human consumption qualify when they meet both chemical-structure similarity and central-nervous-system effect tests. Already-controlled substances and substances with an approved new drug application are excluded from the lookalike definition.
New cannabis product rules for consumers
Effective immediately upon passage and approval, South Dakota defines which cannabinoids count as chemically derived under its controlled-substance rules. These are substances made through chemical reactions that change the molecular structure of a cannabis-derived substance. The definition excludes non-psychoactive cannabinoids and cannabinoids in topical cream products. It also excludes cannabinoids made by decarboxylation of naturally occurring cannabinoid acids without a chemical catalyst. The definition affects consumers and businesses handling covered products; it does not itself ban every cannabinoid product.
Sponsors & Cosponsors
Sponsors
There is no primary sponsor on record.
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
Senate vote • 2/2/2026
Do Pass
Yes: 34 • No: 0
Senate vote • 1/28/2026
Do Pass
Yes: 7 • No: 0
House vote • 1/21/2026
Do Pass
Yes: 61 • No: 7
House vote • 1/20/2026
Do Pass
Yes: 13 • No: 0
Actions Timeline
Signed by the Governor
2/12/2026HouseDelivered to the Governor
2/5/2026HouseSigned by the President
2/4/2026SenateSigned by the Speaker
2/3/2026HouseSenate Do Pass, Passed, YEAS 34, NAYS 0
2/2/2026SenateSenate Deferred to another day, Passed
1/29/2026SenateSenate Health and Human Services Do Pass, Passed, YEAS 7, NAYS 0
1/28/2026SenateScheduled for hearing
1/28/2026SenateReferred to Senate Health and Human Services
1/23/2026SenateFirst Reading Senate
1/22/2026SenateHouse of Representatives Do Pass, Passed, YEAS 61, NAYS 7
1/21/2026HouseHouse Health and Human Services Do Pass, Passed, YEAS 13, NAYS 0
1/20/2026HouseScheduled for hearing
1/20/2026HouseFirst read in House and referred to House Health and Human Services
1/13/2026House
Bill Text
Introduced
12/26/2025
Related Bills
HB 1048, make an appropriation for the expansion of broadband infrastructure and to declare an emergency.
HB 1017, permit the board of a school district to require that certain students receive instruction in alternative settings.
HB 1292, limit the ability of a health carrier to recoup, recover, or retroactively deny previously paid claims.
HB 1262, make an appropriation for a non-residential, school-based, therapeutic services facility in Brown County and to declare an emergency.
HB 1258, require that a property tax bill provide access to a state website providing property tax information.
HB 1257, amend the definition of an abortion.